Invectys Therapeutics

Invectys Therapeutics is a biopharmaceutical company focused on the development of immunotherapy approaches to treat cancer.

Based based in Greater Houston Area, Southern US, Invectys Therapeutics works in biopharma, biotechnology, life science, pharmaceutical, therapeutics, founded in 2010.

Within the biopharma, biotechnology, life science, pharmaceutical, therapeutics space, the company focuses on its core offering rather than a broad product line.

Its base of operations is Greater Houston Area, Southern US.

Its current recorded stage is Series_B.

The company reports a headcount in the c_00011_00050 range.

Total disclosed funding stands at about $64.3M.

Website: www.invectys.com